SBIR/STTR Research Award
GABA Transport Assay
Award amount
$50,000Program and phase
SBIR · Phase IAward year
1993Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- Not reported
- Recipient company
- Synaptic Pharmaceutical Corp.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
GABA transport inhibitors have recently shown promise as anticonvulsants. The cloning of two novel GABA transporters, in addition to the previously cloned neuronal transporter, suggests a diversity of therapeutic targets. However, it is not known whether an effective drug should be a substrate for the transporter or should simply bind, but not be transported. Due to the electrogenic properties of these transporters, transport of substrate is associated with membrane depolarization. Measurements of membrane voltage during transport allow one to distinguish between substrate and non-substrate inhibitors. We will establish a fluorescent assay for transport. We will utilize voltage-sensitive dyes by using the neuronal transporter designated GAT-1. This methodology will allow a rapid screening assay for newly synthesized drugs, and it will provide information as to their mechanism of action. In Phase II, we will extend these studies to the two novel transporters and test selective compounds in animal models of epilepsy.
Technology keywords
Not reported